Purple Biotech Ltd (TLV:PPBT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 4.000
-0.100 (-2.44%)
May 29, 2025, 5:24 PM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 22.80 million as of May 30, 2025. Its market cap has decreased by -55.90% in one year.
Market Cap
22.80M
Enterprise Value
-2.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.00
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 22.80M, an increase of 27.57%. That is a compound annual growth rate of 2.07%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 70.43B |
| Danel (Adir Yeoshua) | 2.38B |
| Kamada | 1.38B |
| Bait Bakfar | 1.16B |
| SofWave Medical | 729.99M |
| BrainsWay | 705.48M |
| Novolog (Pharm-Up 1966) | 701.90M |
| Ilex Medical | 693.44M |